Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Sweden
/
Healthcare
/
Vimian Group
VIMIAN
Vimian Group
Emerging Pet Trends And Digital Diagnostics Will Redefine Animal Healthcare
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
08 Jul 25
Updated
14 Jul 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
SEK 51.65
36.9% undervalued
intrinsic discount
14 Jul
SEK 32.58
Loading
1Y
0.9%
7D
-5.1%
Author's Valuation
SEK 51.6
36.9% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
SEK 51.6
36.9% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-14m
558m
2018
2020
2022
2024
2025
2026
2028
Revenue €557.5m
Earnings €98.1m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
9.47%
Medical Equipment revenue growth rate
0.32%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
5.95%
Calculation
€98.12m
Earnings '28
x
29.62x
PE Ratio '28
=
€2.91b
Market Cap '28
€2.91b
Market Cap '28
/
528.33m
No. shares '28
=
€5.50
Share Price '28
€5.50
Share Price '28
Discounted to 2025 @ 5.80% p.a.
=
€4.64
Fair Value '25
€4.64
Fair Value '25
Converted to SEK @ 11.1758 EUR/SEK Exchange Rate
=
SEK 51.86
Fair Value '25